buprenorfine sandoz wöchentlich 15 µg/h transdermales pflaster
sandoz - buprenorphin - transdermales pflaster - 15 µg/h - buprenorphin 15 mg - buprenorphine
buprenorfine sandoz wöchentlich 20 µg/h transdermales pflaster
sandoz - buprenorphin - transdermales pflaster - 20 µg/h - buprenorphin 20 mg - buprenorphine
buprenorphin/naloxon mylan 8 mg/2 mg sublingualtabletten
mylan germany gmbh (8185157) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 8,64 milligramm; naloxonhydrochlorid-dihydrat (13441) 2,44 milligramm
buprenorphin/naloxon mylan 2 mg/0,5 mg sublingualtabletten
mylan germany gmbh (8185157) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 2,16 milligramm; naloxonhydrochlorid-dihydrat (13441) 0,61 milligramm
buprenorphin/naloxon g.l. pharma 8 mg/2 mg sublingualtabletten
g.l. pharma gmbh (8070827) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 8,64 milligramm; naloxonhydrochlorid-dihydrat (13441) 2,44 milligramm
buprenorphin/naloxon g.l. pharma 2 mg/0,5 mg sublingualtabletten
g.l. pharma gmbh (8070827) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 2,16 milligramm; naloxonhydrochlorid-dihydrat (13441) 0,61 milligramm
buprenorphin/naloxon molteni 8 mg/2 mg sublingualtabletten
l. molteni & c. dei fratelli alitti - societa di esercizio - s.p.a. (8024342) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 8,64 milligramm; naloxonhydrochlorid-dihydrat (13441) 2,44 milligramm
buprenorphin/naloxon molteni 2 mg/0,5 mg sublingualtabletten
l. molteni & c. dei fratelli alitti - societa di esercizio - s.p.a. (8024342) - buprenorphinhydrochlorid; naloxonhydrochlorid-dihydrat - sublingualtablette - teil 1 - sublingualtablette; buprenorphinhydrochlorid (20181) 2,16 milligramm; naloxonhydrochlorid-dihydrat (13441) 0,61 milligramm
buprenorphine teva wöchentlich 5 µg/h transdermales pflaster
teva pharma belgium - buprenorphin - transdermales pflaster - 5 µg/h - buprenorphin 5 mg - buprenorphine
buprenorphine teva wöchentlich 10 µg/h transdermales pflaster
teva pharma belgium - buprenorphin - transdermales pflaster - 10 µg/h - buprenorphin 10 mg - buprenorphine